# Lubrizol Life Science Health opens $60M commercial manufacturing facility in Bethlehem, Pennsylvania

Lubrizol's CDMO, now renamed Lubrizol Life Science Health (LLS Health), opened a new 5,000 sq. ft commercial manufacturing facility in Bethlehem, Pa., as part of a $60 million investment.

- Type: Expansion
- Announced: 2019-11-05
- Where: Bethlehem, Pennsylvania, United States
- Value: $60.0M
- Starts operating: 5 Nov 2019
- Status: completed
- Products: drug products, sterile multi-use topical ophthalmic delivery device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lubrizol](https://endata.com/companies/11149.md)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2019/11/05/1941419/0/en/Particle-Sciences-becomes-Lubrizol-Life-Science-Health.html), 2019-11-05: "LLS Health announced its expanded commercial-scale capabilities for drug product manufacturing with the opening of its new 5,000 sq. ft commercial manufacturing facility in Bethlehem, Pa., as part of a $60 million investment."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.